Cite
HARVARD Citation
Elliott, M. et al. (n.d.). Botulinum neurotoxin B engineered for increased receptor affinity has improved clinical potential. Toxicon. pp. S27-S28. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Elliott, M. et al. (n.d.). Botulinum neurotoxin B engineered for increased receptor affinity has improved clinical potential. Toxicon. pp. S27-S28. [Online].